| |
| | News: INEX and Alnylam Announce Allowance of New U.S. Patent Covering Delivery of RNAi Therapeutics. Genetic ... |
 | | Inex Pharmaceuticals Corporation (TSX: IEX) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in a patent application that covers nucleic acid-lipid compositions, including cationic liposomes, a family of specialized lipid molecules. |
 | | There are forward-looking statements by INEX contained herein that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticipates," "intends," "expects," and similar expressions. |
 | | INEX disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments. |
| www.genengnews.com /news/bnitem.aspx?name=13869739 (881 words) |
|